[
  {
    "ts": "2026-02-18T20:10:53+00:00",
    "headline": "Assessing West Pharmaceutical Services (WST) Valuation After Earnings Beat Guidance And US$1b Buyback Announcement",
    "summary": "West Pharmaceutical Services (WST) is back in focus after reporting fourth quarter and full year 2025 results that topped expectations, issuing 2026 growth guidance, and unveiling a new US$1b share repurchase program. See our latest analysis for West Pharmaceutical Services. Despite the latest earnings beat, dividend declaration and new US$1b buyback plan, West Pharmaceutical Services’ recent momentum has cooled, with a 30 day share price return of 6.39% decline and a 1 year total shareholder...",
    "url": "https://finance.yahoo.com/news/assessing-west-pharmaceutical-services-wst-201053561.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7c80415c-d4c0-347b-a7b5-228b76db4c7c",
      "content": {
        "id": "7c80415c-d4c0-347b-a7b5-228b76db4c7c",
        "contentType": "STORY",
        "title": "Assessing West Pharmaceutical Services (WST) Valuation After Earnings Beat Guidance And US$1b Buyback Announcement",
        "description": "",
        "summary": "West Pharmaceutical Services (WST) is back in focus after reporting fourth quarter and full year 2025 results that topped expectations, issuing 2026 growth guidance, and unveiling a new US$1b share repurchase program. See our latest analysis for West Pharmaceutical Services. Despite the latest earnings beat, dividend declaration and new US$1b buyback plan, West Pharmaceutical Services’ recent momentum has cooled, with a 30 day share price return of 6.39% decline and a 1 year total shareholder...",
        "pubDate": "2026-02-18T20:10:53Z",
        "displayTime": "2026-02-18T20:10:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4G9ppBeYPHN150Vf7ljszA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rJ2VkF_7pHDs8.rNQqRscw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-west-pharmaceutical-services-wst-201053561.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-west-pharmaceutical-services-wst-201053561.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]